News

FIS Secures €770 Million Bond Offering to Boost Growth

FIS Secures €770 Million Bond Offering to Boost Growth

FIS Completes Significant Bond Issuance

FIS has recently completed a notable bond issuance that attracted remarkable interest from institutional investors and was significantly oversubscribed.

Details of the Bond Issuance

On its recent transaction, FIS – Fabbrica Italiana Sintetici – confirmed the settlement of €770 million in Senior Secured Notes. This issuance includes €300 million in Fixed Rate Notes with an interest of 5.250% per annum and €470 million in Floating Rate Notes tied to the three-month Euribor plus 325 basis points.

The Market's Confidence

The Notes, due for maturity in five years, underscore the market's positive outlook towards FIS’s strategy. The combined principal amount was admitted to listing on the Luxembourg Stock Exchange's Official List as well as trading on the Euro MTF Market.

Enhanced Financial Position

In conjunction with this issuance, FIS increased its existing revolving credit facility from €80 million to €160 million, which notably boosts its liquidity and financial flexibility.

Significant Investor Interest

The overwhelming demand for the Notes reflects strong investor confidence in FIS's operational plans and fiscal fundamentals. This issuance clearly highlights a positive endorsement from the market regarding FIS’s growth trajectory.

Upgrades in Credit Ratings

As part of this successful bond issuance, FIS garnered an upgrade in its Corporate Family Rating from Moody's, elevating from B3 to B2 with a stable outlook. Fitch Ratings also upgraded its Issuer Default Rating from B to B+.

Expert Insights

Daniele Piergentili, the CEO and Chairman of FIS, expressed satisfaction with the bond issuance's outcomes, emphasizing that the strong investor response illustrates their faith in FIS's business model and future strategies.

Key Collaborators in the Process

Leading financial institutions including BNP Paribas and Goldman Sachs International acted as joint global coordinators, in collaboration with various other banks facilitating the book-running process, showcasing a solid advisory team supporting the initiative.

About FIS

Founded in 1957, FIS is recognized as a leader in the API sector across Europe, producing active pharmaceutical ingredients and emphasizing R&D. With a workforce exceeding 2,300, they operate multiple plants in Italy and have established a presence in North America, Japan, China, and India.

Contact Information

Micaela Colamasi leads corporate communication. For further insights or queries, interested parties can contact their office directly at +39 338 71 88 939.

Frequently Asked Questions

What is the total amount raised in the bond issuance?

FIS successfully raised €770 million through its latest bond issuance.

Who are the main lenders involved in this bond issue?

BNP Paribas and Goldman Sachs International served as the main global coordinators in this transaction.

How does this bond issuance impact FIS's financial outlook?

The bond issuance enhances FIS's liquidity and is a sign of strong confidence from investors regarding its financial strategies.

What ratings have been associated with FIS following the issuance?

FIS received various upgrades from credit rating agencies, reflecting improved financial standings and future outlooks.

What is FIS's position in the pharmaceutical industry?

FIS is one of the top players in the European pharmaceutical sector, specializing in the development and production of active pharmaceutical ingredients.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

The Greathouse Company and Roebuck Landscaping Partnership

Updated Category News Views 174

The Greathouse Company Partners with Roebuck Landscaping The Greathouse Company, a beloved family-owned landscaping firm established in Nashville, has taken a significant step by partnering with Roebuck Landscaping. This collaboration aims to blend their strengths, bringing enhanced services and growth opportunities to both companies involved. Building on a Legacy Founded...

Continue Reading
Exploring CVS Health Options Market Trends and Insights

Updated Category News Views 171

Recent Insights into Options Trading for CVS Health There has been notable bullish activity surrounding CVS Health, a significant entity in the healthcare industry. An examination of the options market reveals intriguing trends and insights that investors should pay attention to. Among the recent trades analyzed, a considerable 62% of traders exhibited a bullish outlook...

Continue Reading
Citius Oncology Shines with Promising Financial Outcomes

Updated Category News Views 109

Citius Oncology Reports Strong Growth and Financial Results Citius Oncology, Inc. (Nasdaq: CTOR) is making waves in the oncology sector with its recent financial outcomes and business developments. This year marked a turning point for the company, especially following the launch of LYMPHIR™, its innovative cancer immunotherapy, which debuted in the U.S. market in...

Continue Reading
Pioneering Digital Alerting System Enhances Ambulance Safety

Updated Category News Views 163

Introducing a Game-Changing Partnership A groundbreaking pilot program is currently in progress, featuring collaboration between the South East Coast Ambulance Service NHS Foundation Trust (SECAMB), HAAS Alert, and ACETECH. This partnership represents a pivotal moment in efforts to enhance road safety and boost the efficiency of emergency responses. Exploring the Safety...

Continue Reading
Strategic Collaboration Unveiled: NETCLASS and RunSun Join Forces

Updated Category News Views 149

NETCLASS TECHNOLOGY INC and RunSun Cloud Collaboration In an exciting development for the tech industry, NETCLASS TECHNOLOGY INC (NASDAQ: NTCL), known for its innovative B2B smart education IT solutions, has entered into a significant partnership with RunSun Cloud Pte. Ltd. This collaboration aims to enhance AI computing infrastructure and drive application development...

Continue Reading